減価償却費、資本剰余金合計、研究開発費 - ヘルスケアビジネス他1件
- 【期間】
| 年度 | 減価償却費 | 資本剰余金合計 | 研究開発費 - ヘルスケアビジネス | 受取配当金 |
|---|
| 2007/03 | - | | 888億 | | - | | - | |
| 2008/03 | - | | 888億 | -0% | - | | 279億 | |
| 2009/03 | - | | 888億 | ±0% | - | | 88.6億 | -68.2% |
| 2010/03 | - | | 888億 | ±0% | - | | 346億 | +289.8% |
| 2011/03 | - | | 888億 | ±0% | - | | 91.3億 | -73.6% |
| 2012/03 | - | | 888億 | ±0% | - | | 52.4億 | -42.7% |
| 2013/03 | 30.3億 | | 888億 | ±0% | - | | 40.4億 | -22.9% |
| 2014/03 | 29.3億 | -3.2% | 888億 | +0% | - | | 49.7億 | +23.2% |
| 2015/03 | 30.1億 | +2.5% | 888億 | -0% | - | | 133億 | +167.2% |
| 2016/03 | 26.9億 | -10.4% | 888億 | ±0% | - | | - | |
| 2017/03 | 29.1億 | +8.2% | 888億 | ±0% | - | | - | |
| 2018/03 | 32.7億 | +12.2% | 888億 | ±0% | - | | - | |
| 2019/03 | 34.7億 | +6.2% | 888億 | ±0% | 67.1億 | | - | |
| 2020/03 | 41.3億 | +18.9% | 888億 | ±0% | 68.4億 | +2% | - | |
| 2021/03 | 41.5億 | +0.5% | 888億 | ±0% | 69.2億 | +1.2% | - | |
| 2022/03 | 43.2億 | +4.1% | 888億 | ±0% | 78.5億 | +13.4% | - | |
| 2023/03 | 49億 | +13.6% | 888億 | ±0% | 79.1億 | +0.7% | - | |
